These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9119285)

  • 1. Haematology and coagulation indices in paired samples of arterial and venous blood from patients with arterial disease.
    Blann AD; Adams RA; Katai F; Ashleigh R; Taberner DA
    Haemostasis; 1996; 26(2):72-8. PubMed ID: 9119285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
    Blann AD; Dobrotova M; Kubisz P; McCollum CN
    Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic and prothrombotic markers in extensive slow-flow vascular malformations: implications for antiangiogenic/antithrombotic strategies.
    Redondo P; Aguado L; Marquina M; Paramo JA; Sierra A; Sánchez-Ibarrola A; Martínez-Cuesta A; Cabrera J
    Br J Dermatol; 2010 Feb; 162(2):350-6. PubMed ID: 19769632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cell activation and blood coagulation in critically ill patients with lung injury.
    Wenzel C; Kofler J; Locker GJ; Laczika K; Quehenberger P; Frass M; Knöbl P
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):853-8. PubMed ID: 12503477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial marker proteins in hyperhomocysteinemia.
    de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
    Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemias and fibrinolysis.
    Puccetti L; Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Auteri A
    Ital Heart J; 2002 Oct; 3(10):579-86. PubMed ID: 12478815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are coagulation studies on blood sampled from arterial lines valid?
    Heap MJ; Ridley SA; Hodson K; Martos FJ
    Anaesthesia; 1997 Jul; 52(7):640-5. PubMed ID: 9244021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered endothelial function following the Fontan procedure.
    Binotto MA; Maeda NY; Lopes AA
    Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.
    Erem C; Hacihasanoğlu A; Celik S; Ovali E; Ersöz HO; Ukinç K; Deger O; Telatar M
    Med Princ Pract; 2005; 14(1):22-30. PubMed ID: 15608477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
    Lip PL; Blann AD; Jones AF; Lip GY
    Eye (Lond); 1998; 12 ( Pt 2)():245-51. PubMed ID: 9683948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity.
    Blann A; Bignell A; McCollum C
    Atherosclerosis; 1998 Aug; 139(2):317-22. PubMed ID: 9712338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of haematological, haemostatic, and inflammatory parameters in canine venous and arterial blood samples.
    Palsgaard-Van Lue A; Jensen AL; Strøm H; Kristensen AT
    Vet J; 2007 May; 173(3):664-8. PubMed ID: 16690335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation, fibrinolytic system activation and endothelial dysfunction in patients with mitral stenosis and sinus rhythm.
    Topaloglu S; Boyaci A; Ayaz S; Yilmaz S; Yanik O; Ozdemir O; Soylu M; Demir AD; Aras D; Kisacik HL; Korkmaz S
    Angiology; 2007; 58(1):85-91. PubMed ID: 17351162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in endothelial, leucocyte and platelet markers following contrast medium injection during angiography in patients with peripheral artery disease.
    Blann AD; Adams R; Ashleigh R; Naser S; Kirkpatrick U; McCollum CN
    Br J Radiol; 2001 Sep; 74(885):811-7. PubMed ID: 11560828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation and fibrinolysis in chronic venous insufficiency.
    Blomgren L; Johansson G; Siegbahn A; Bergqvist D
    Vasa; 2001 Jul; 30(3):184-7. PubMed ID: 11582948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic response to acute physical exercise in healthy adolescents.
    Ribeiro J; Almeida-Dias A; Ascensão A; Magalhães J; Oliveira AR; Carlson J; Mota J; Appell HJ; Duarte J
    J Sci Med Sport; 2007 Jun; 10(3):164-9. PubMed ID: 16844409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparison of the coagulation factors in arterial and venous blood.
    Ozsoylu S
    Acta Haematol; 1969; 41(5):303-8. PubMed ID: 4980432
    [No Abstract]   [Full Text] [Related]  

  • 19. Severity of venous insufficiency is related to the density of microvascular deposition of PAI-1, uPA and von Willebrand factor.
    Kolbach DN; Hamulyák K; Prins MH; Neumann HA; Cleutjens JP
    Vasa; 2004 Feb; 33(1):19-24. PubMed ID: 15061043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
    Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.